This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Weilin Wang - Innovator in Hemostatic Materials
Introduction
Weilin Wang is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of medical materials, particularly in the development of innovative hemostatic solutions. His work focuses on creating effective materials for rapid clotting and wound management.
Latest Patents
Weilin Wang holds a patent for a "Double-crosslinked fibrin gel, raw material composition and kit thereof, and application thereof." This invention provides a double-crosslinked fibrin gel, which is a solid hydrogel composed of a network structure with both blocking and adhesion functions. The three-dimensional fibrin network disperses throughout the hydrogel, enhancing its effectiveness. The kit developed for this gel allows for the preparation of an in-situ rapid clotting and hemostatic material, which is crucial for managing accidental trauma or surgical wounds. He has 1 patent to his name.
Career Highlights
Weilin Wang is affiliated with Zhejiang University, where he conducts research and development in the field of medical materials. His innovative approach has led to advancements in hemostatic technologies, making a significant impact on medical practices.
Collaborations
Weilin Wang has collaborated with notable colleagues, including Zhengwei Mao and Lisha Yu. Their combined expertise has contributed to the success of their research projects and innovations.
Conclusion
Weilin Wang's contributions to the field of hemostatic materials exemplify the importance of innovation in medical technology. His work not only enhances patient care but also paves the way for future advancements in wound management.